A share price of Ventyx Biosciences Inc [VTYX] is currently trading at $2.16, up 3.85%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The VTYX shares have gain 11.34% over the last week, with a monthly amount drifted -6.09%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Ventyx Biosciences Inc [NASDAQ: VTYX] stock has seen the most recent analyst activity on March 12, 2024, when Wells Fargo upgraded its rating to a Overweight and also boosted its price target to $16 from $7. Previously, Oppenheimer upgraded its rating to Outperform on March 12, 2024, and kept the price target unchanged to $12. On November 07, 2023, downgrade downgraded it’s rating to Equal Weight and revised its price target to $8 on the stock. Stifel downgraded its rating to a Hold but stick to its price target of $6 on November 07, 2023. Oppenheimer downgraded its rating to a Perform. Morgan Stanley downgraded its rating to Equal-Weight for this stock on November 07, 2023, and downed its price target to $6. In a note dated November 07, 2023, H.C. Wainwright downgraded an Neutral rating on this stock.
Ventyx Biosciences Inc experienced fluctuations in its stock price throughout the past year between $1.67 and $11.48. Currently, Wall Street analysts expect the stock to reach $33.86 within the next 12 months. Ventyx Biosciences Inc [NASDAQ: VTYX] shares were valued at $2.16 at the most recent close of the market. An investor can expect a potential return of 1467.59% based on the average VTYX price forecast.
Analyzing the VTYX fundamentals
Gross Profit Margin for this corporation currently stands at -0.05% with Operating Profit Margin at -152.58%, Pretax Profit Margin comes in at -141.75%, and Net Profit Margin reading is -141.75%. To continue investigating profitability, this company’s Return on Assets is posted at -0.51, Equity is -0.55 and Total Capital is -0.57. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.03 points at the first support level, and at 1.90 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.24, and for the 2nd resistance point, it is at 2.31.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Ventyx Biosciences Inc [NASDAQ:VTYX] is 23.52. In addition, the Quick Ratio stands at 23.52 and the Cash Ratio stands at 5.02.
Transactions by insiders
Recent insider trading involved Nuss John, CHIEF SCIENTIFIC OFFICER, that happened on Dec 27 ’24 when 21119.0 shares were sold. Officer, Nuss John completed a deal on Dec 27 ’24 to buy 21119.0 shares. Meanwhile, Director Gujrathi Sheila bought 0.13 million shares on Dec 23 ’24.
